Gunnveig Grødeland

Image of Gunnveig Grødeland
Norwegian version of this page
Username
Visiting address Sognsvannsveien 20 Rikshospitalet 0027 Oslo
Postal address Postboks 4950 Nydalen OUS HF Rikshospitalet 0424 Oslo
Tags: Influenza, Immunology, Vaccine molecules, USA

Publications

  • Jyssum, Ingrid; Kared, Hassen; Tran, Trung; Tveter, Anne Therese; Provan, Sella Aarrestad & Sexton, Joseph [Show all 22 contributors for this article] (2021). Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study. The Lancet Rheumatology. doi: 10.1016/S2665-9913%2821%2900394-5.
  • Nguyen, D; Simmonds, P; Steenhuis, M; Wouters, E; Desmecht, D & Garigliany, M [Show all 32 contributors for this article] (2021). SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data. Eurosurveillance. ISSN 1025-496X. doi: 10.2807/1560-7917.ES.2021.26.27.2100568.
  • Ianevski, Aleksandr; Yao, Rouan; Zusinaite, Eva; Lello, Laura Sandra; Wang, Sainan & Jo, Eunji [Show all 28 contributors for this article] (2021). Synergistic interferon-alpha-based combinations for treatment of sars-cov-2 and other viral infections. Viruses. ISSN 1999-4915. 13:2489(12), p. 1–18. doi: 10.3390/v13122489.
  • Zhou, Fan; Hansen, Lena; Pedersen, Gabriel Kristian; Grødeland, Gunnveig & Cox, Rebecca Jane (2021). Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection. Frontiers in Immunology. ISSN 1664-3224. 12. doi: 10.3389/fimmu.2021.747774.
  • Andersen, Tor Kristian; Bodin, Johanna Eva; Oftung, Fredrik; Bogen, Bjarne; Mjaaland, Siri & Grødeland, Gunnveig (2021). Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief. Frontiers in Immunology. ISSN 1664-3224. 12:747032, p. 1–14. doi: 10.3389/fimmu.2021.747032. Full text in Research Archive
  • Ianevski, Aleksandr; Yao, Rouan; Lysvand, Hilde; Grødeland, Gunnveig; Legrand, Nicolas & Oksenych, Valentyn [Show all 10 contributors for this article] (2021). Nafamostat–interferon-α combination suppresses sars-cov-2 infection in vitro and in vivo by cooperatively targeting host tmprss2. Viruses. ISSN 1999-4915. 13(9), p. 1–8. doi: 10.3390/v13091768.
  • Taxt, Arne Michael; Grødeland, Gunnveig; Lind, Andreas & Müller, Fredrik (2020). Status for vaksineutvikling mot covid-19. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 140(13), p. 1–11. doi: 10.4045/tidsskr.20.0676.
  • Grødeland, Gunnveig; Baranowska-Hustad, Marta Natalia; Abadejos, Justin; Blane, Tanja R.; Teijaro, John & Nemazee, David [Show all 7 contributors for this article] (2020). Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin. Frontiers in Immunology. ISSN 1664-3224. 11:431, p. 1–13. doi: 10.3389/fimmu.2020.00431. Full text in Research Archive
  • Grødeland, Gunnveig; Fossum, Even & Bogen, Bjarne (2019). Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs. Vaccine. ISSN 0264-410X. 38(6), p. 1280–1285. doi: 10.1016/j.vaccine.2019.11.084. Full text in Research Archive
  • Andersen, Tor Kristian; Huszthy, Peter Csaba; Gopalakrishnan, Ramakrishna Prabhu; Jacobsen, Johanne Tracey; Fauskanger, Marte & Tveita, Anders Aune [Show all 8 contributors for this article] (2019). Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules. npj Vaccines. ISSN 2059-0105. 4:9, p. 1–13. doi: 10.1038/s41541-019-0101-0. Full text in Research Archive
  • Mooij, Petra; Grødeland, Gunnveig; Koopman, Gerrit; Andersen, Tor Kristian; Mortier, Daniella & Nieuwenhuis, Ivonne G. [Show all 10 contributors for this article] (2019). Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza. Vaccine. ISSN 0264-410X. 37(6), p. 817–826. doi: 10.1016/j.vaccine.2018.12.049. Full text in Research Archive
  • Braathen, Ranveig; Spång, Heidi Cecilie Larsen; Lindeberg, Mona Mari; Fossum, Even; Grødeland, Gunnveig & Fredriksen, Agnete [Show all 7 contributors for this article] (2018). The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccine Are Influenced by Specificity for APC Surface Molecules. ImmunoHorizons. ISSN 2573-7732. 2(1), p. 38–53. doi: 10.4049/immunohorizons.1700038. Full text in Research Archive
  • Anderson, Ane Marie; Baranowska-Hustad, Marta Natalia; Braathen, Ranveig; Grødeland, Gunnveig & Bogen, Bjarne (2018). Simultaneous targeting of multiple hemagglutinins to APCs for induction of broad immunity against influenza. Journal of Immunology. ISSN 0022-1767. 200(6), p. 2057–2066. doi: 10.4049/jimmunol.1701088.
  • Andersen, Tor Kristian; Zhou, Fan; Cox, Rebecca Jane; Bogen, Bjarne & Grødeland, Gunnveig (2017). A DNA vaccine that targets hemagglutinin to antigen-presenting cells protects mice against H7 influenza. Journal of Virology. ISSN 0022-538X. 91:e01340-17(23), p. 1–13. doi: 10.1128/JVI.01340-17. Full text in Research Archive
  • Lambert, Laura; Kinnear, Ekaterina; McDonald, Jacqueline U.; Grødeland, Gunnveig; Bogen, Bjarne & Stubsrud, Elisabeth [Show all 9 contributors for this article] (2016). DNA vaccines encoding antigen targeted to MHC class II induce influenza-specific CD8+ T cell responses, enabling faster resolution of influenza disease. Frontiers in Immunology. ISSN 1664-3224. 7:321. doi: 10.3389/fimmu.2016.00321.
  • Grødeland, Gunnveig; Fredriksen, Agnete; Løset, Geir Åge; Vikse, Elisabeth Lea; Fugger, Lars & Bogen, Bjarne (2016). Antigen targeting to human HLA Class II molecules increases efficacy of DNA vaccination. Journal of Immunology. ISSN 0022-1767. 197(9), p. 3575–3585. doi: 10.4049/jimmunol.1600893.
  • Baranowska, Marta Natalia; Hauge, Anna G; Hoornaert, Chloe; Bogen, Bjarne & Grødeland, Gunnveig (2015). Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza. Vaccine. ISSN 0264-410X. 33(49), p. 6988–6996. doi: 10.1016/j.vaccine.2015.08.094.
  • Grødeland, Gunnveig; Fossum, Even & Bogen, Bjarne (2015). Polarizing T and B cell responses by APC-targeted subunit vaccines. Frontiers in Immunology. ISSN 1664-3224. 6. doi: 10.3389/fimmu.2015.00367.
  • Grødeland, Gunnveig & Bogen, Bjarne (2015). Efficient vaccine against pandemic influenza: Combining DNA vaccination and targeted delivery to MHC class II molecules. Expert Review of Vaccines. ISSN 1476-0584. 14(6), p. 805–814. doi: 10.1586/14760584.2015.1029919.
  • Fossum, Even; Grødeland, Gunnveig; Terhorst, Dorothea; Tveita, Anders; Vikse, Elisabeth Lea & Mjaaland, Siri [Show all 9 contributors for this article] (2015). Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus. European Journal of Immunology. ISSN 0014-2980. 45(2), p. 624–635. doi: 10.1002/eji.201445080.
  • Grødeland, Gunnveig; Mjaaland, Siri; Tunheim, Gro; Fredriksen, Agnete & Bogen, Bjarne (2013). The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype. PLOS ONE. ISSN 1932-6203. 8(11). doi: 10.1371/journal.pone.0080008. Full text in Research Archive
  • Grødeland, Gunnveig; Mjaaland, Siri; Roux, Kenneth H.; Fredriksen, Agnete & Bogen, Bjarne (2013). DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza. Journal of Immunology. ISSN 0022-1767. 191(6), p. 3221–3231. doi: 10.4049/jimmunol.1300504.
  • Ruffini, Pier Adelchi; Grødeland, Gunnveig; Fredriksen, Agnete & Bogen, Bjarne (2010). Human chemokine MIP1 alpha increases efficiency of targeted DNA fusion vaccines. Vaccine. ISSN 0264-410X. 29(2), p. 191–199. doi: 10.1016/j.vaccine.2010.10.057.
  • Huang, Tien-Sheng; Grødeland, Gunnveig; Grodeland, G; Sleire, Linda; Wang, Meng Yu & Kvalheim, Gunnar [Show all 7 contributors for this article] (2009). Induction of Circadian Rhythm in Cultured Human Mesenchymal Stem Cells by Serum Shock and cAMP Analogs in Vitro. Chronobiology International. ISSN 0742-0528. 26(2), p. 242–257. doi: 10.1080/07420520902766025.

View all works in Cristin

  • Fossum, Even; Grødeland, Gunnveig & Mamelund, Svenn-Erik (2022). Pandemier og samfunn. [Radio]. Vaksinebloggen.no.
  • Grødeland, Gunnveig & Lund, Joacim (2021). Koronahøsten: Nå kommer bølge fire.
  • Grødeland, Gunnveig (2021). Vaccine development against a previously unknown viral threat – what have we learned from the race against Covid-19?
  • Grødeland, Gunnveig (2021). En tabloid gjennomgang av de ulike vaksinene.
  • Grødeland, Gunnveig & Løkke, Eirik (2021). Alt du trenger å vite om vaksiner – og litt til!
  • Grødeland, Gunnveig & Løkke, Eirik (2021). Er omikron veien ut av pandemien?
  • Grødeland, Gunnveig (2021). Vaksineteknologiens historie.
  • Neset, Iver & Grødeland, Gunnveig (2021). Politisk autoimmun.
  • Grødeland, Gunnveig; Eikeland, Ole & Stavrum, Gunnar (2021). Fyres opp av spørsmål om vaksine: Helt udiskutabelt!
  • Grødeland, Gunnveig (2021). Omikron.
  • Grødeland, Gunnveig (2021). Vaksiner mot SARS-CoV-2: Erfaring og status.
  • Grødeland, Gunnveig (2021). Kan ny vaksineteknologi gjøre oss bedre rustet til å bekjempe viruspandemier? .
  • Grødeland, Gunnveig (2021). Fremtidens vaksiner, og mRNA mot virus X?
  • Grødeland, Gunnveig (2021). SARS-CoV-2 ble et paradigmeskifte for vaksineutvikling.
  • Grødeland, Gunnveig (2021). SARS-CoV-2 ble et paradigmeskifte for vaksineutvikling.
  • Grødeland, Gunnveig (2021). Influenza vaccine that can be rapidly produced to counter an emerging pandemic threat.
  • Grødeland, Gunnveig; Fossum, Even & Dudman, Susanne Gjeruldsen (2021). Vaksinepodden.no: Vaksinene er her - hva nå?
  • Grødeland, Gunnveig; Fossum, Even & Anderson, Ane Marie (2021). Vaksinepodden.no: SARS-CoV-2: forebygging og testing.
  • Grødeland, Gunnveig; Fossum, Even & Andersen, Tor Kristian (2021). Vaksinepodden.no: Mutasjoner og virusvarianter.
  • Grødeland, Gunnveig; Fossum, Even & Anderson, Ane Marie (2021). Vaksinepodden.no: Vaksineeffekt mot Covid-19.
  • Grødeland, Gunnveig; Fossum, Even & Anderson, Ane Marie (2021). Vaksinepodden.no: Koronamyter.
  • Grødeland, Gunnveig; Fossum, Even & Anderson, Ane Marie (2021). Vaksinepodden.no: Myter rundt Covid-19-vaksinene.
  • Grødeland, Gunnveig; Fossum, Even & Befring, Anne Kjersti (2021). Vaksinepodden.no: Vektorvaksiner og frivillighet.
  • Grødeland, Gunnveig; Fossum, Even & Braathen, Ranveig (2021). Vaksinepodden.no: Beskyttende effekt.
  • Grødeland, Gunnveig; Fossum, Even & Befring, Anne Kjersti (2021). Vaksinepodden.no: Koronapass og vaksinering av barn.
  • Grødeland, Gunnveig; Fossum, Even & Inngjerdingen, Marit (2021). Vaksinepodden.no: Medfødt immunitet.
  • Grødeland, Gunnveig; Fossum, Even & Anderson, Ane Marie (2021). Vaksinepodden.no: Pandemien etter vaksinering.
  • Grødeland, Gunnveig; Fossum, Even & Anderson, Ane Marie (2021). Vaksinepodden: Hva har vi lært fra pandemien?
  • Grødeland, Gunnveig; Fossum, Even & Braathen, Ranveig (2021). Vaksinepodden: Vokterceller og T-celler.
  • Grødeland, Gunnveig; Fossum, Even & Braathen, Ranveig (2021). Vaksinepodden: RNA-vaksiner: Før, nå og fremover.
  • Grødeland, Gunnveig; Fossum, Even & Pettersen, Frank O. (2021). Vaksinepodden: Malaria.
  • Grødeland, Gunnveig; Fossum, Even & Størdal, Ketil (2021). Vaksinepodden: Barn, Covid og vaksiner.
  • Grødeland, Gunnveig; Sørvoll, Ingvild Hausberg; Befring, Anne Kjersti; Gran, Jon Michael; Krokstad, Steinar & Vorland, lars (2021). Vent på vaksinen du får tilbudt i det nasjonale vaksineprogrammet. VG : Verdens gang. ISSN 0805-5203.
  • Befring, Anne Kjersti; Sørvoll, Ingvild Hausberg; Grødeland, Gunnveig; Krokstad, Steinar; Gran, Jon Michael & Pettersen, Frank O. (2021). Tåler neppe at friske dør. Dagbladet. ISSN 0805-3766.
  • Grødeland, Gunnveig (2021). Influensavaksiner skreddersydd for eldre. Morgenbladet. ISSN 0805-3847.
  • Vaksdal, Hanna Hartmark & Grødeland, Gunnveig (2021). Hvor effektive er covid-19-vaksinene hos eldre? Tidsskrift for Den norske legeforening. ISSN 0029-2001. 141(18). doi: 10.4045/tidsskr.21.0748.
  • Andersen, Tor Kristian & Grødeland, Gunnveig (2021). The vaccines can keep up with the SARS-CoV-2 mutations. Tidsskrift for Den norske legeforening. ISSN 0029-2001. doi: 10.4045/tidsskr.21.0080.
  • Westin, Steinar & Grødeland, Gunnveig (2021). Corona: Krever strengere tiltak - er bakpå. "Vi er antakelig dårligere rustet nå. Regjeringen må ta i bruk alle tiltak den kan for å forhindre smitteimport og spredning. Dagbladet. ISSN 0805-3766. p. 4–5.
  • Westin, Steinar; Forland, Frode; Grødeland, Gunnveig; Klein, Jørn & Stoltenberg, Camilla (2021). Corona-krisa: Dette kan vi vente oss, en fjerde smittebølge? Dagbladet. ISSN 0805-3766. p. 4–5.
  • Grødeland, Gunnveig; Fossum, Even & Anderson, Ane Marie (2020). Vaksinepodden.no: SARS-CoV-2 - immunitet.
  • Grødeland, Gunnveig; Fossum, Even & Anderson, Ane Marie (2020). Vaksinepodden.no: SARS-CoV-2 - vaksiner.
  • Grødeland, Gunnveig; Fossum, Even & Braathen, Ranveig (2020). Vaksinepodden.no: Covid-19 vaksiner - fra Oxford til Sputnik V.
  • Grødeland, Gunnveig; Fossum, Even & Anderson, Ane Marie (2020). Vaksinepodden.no: Influensa i koronaens tid.
  • Grødeland, Gunnveig; Fossum, Even & Andersen, Tor Kristian (2020). Vaksinepodden.no: RNA som vaksiner.
  • Grødeland, Gunnveig; Fossum, Even & Anderson, Ane Marie (2020). Vaksinepodden.no: Universelle vaksiner.
  • Grødeland, Gunnveig; Fossum, Even & Andersen, Jan Terje (2020). Vaksinepodden.no: Antistoffer.
  • Grødeland, Gunnveig & Fossum, Even (2020). Vaksinepodden.no: Nå kommer vaksinene mot covid-19.
  • Anderson, Ane Marie; Gudjonsson, Arnar; Fossum, Even & Grødeland, Gunnveig (2020). Gjør Norge nok for å bekjempe covid-19? Morgenbladet. ISSN 0805-3847.
  • Grødeland, Gunnveig (2020). Nye resultater styrker håpet om en koronavaksine i 2021. Morgenbladet. ISSN 0805-3847.
  • Einevoll, Gaute & Grødeland, Gunnveig (2020). Om vaksiner, spesielt koronavaksiner. [Internet]. Podcast: Vett og vitenskap med Gaute Einevoll.
  • Grødeland, Gunnveig (2019). A novel influenza vaccine that can rapidly be deployed to quench an emerging pandemic.
  • Grødeland, Gunnveig (2019). A novel vaccine platform that can rapidly be deployed to quench an emerging pandemic.
  • Grødeland, Gunnveig (2019). A novel DNA vaccine aiming to quench pandemic threats.
  • Grødeland, Gunnveig (2019). A novel vaccine platform that can rapidly be deployed to quench an emerging pandemic.
  • Grødeland, Gunnveig (2019). DNA vaccination with APC-targeted antigens for prevention of influenza pandemics.
  • Grødeland, Gunnveig (2019). Nye og mer effektive DNA-vaksiner mot influensa og pandemi.
  • Bjerkan, Louise; Braathen, Ranveig; Gudjonsson, Arnar; Grødeland, Gunnveig; Visweswaran, Ganesh Ram & Bogen, Bjarne (2018). Targeted DNA vaccination induce protective immune responses against malaria .
  • Bjerkan, Louise; Braathen, Ranveig; Gudjonsson, Arnar; Grødeland, Gunnveig; Visweswaran, Ganesh Ram & Bogen, Bjarne (2018). An APC-targeted PfRH5 containing DNA vaccine induce protective immune responses against Plasmodium falciparum .
  • Hinke, Daniëla Maria; Spång, Heidi; Fossum, Even; Grødeland, Gunnveig; Bogen, Bjarne & Braathen, Ranveig (2018). MHC class II targeted DNA vaccine is most efficient in the induction of protective antibodies against influenza.
  • Hoornaert, Chloé Juliette; Grødeland, Gunnveig & Bogen, Bjarne (2011). Potential of Targeted DNA Vaccines against Conserved Influenza Proteins. Scandinavian Journal of Immunology. ISSN 0300-9475. 73(4), p. 387–387.
  • Lindeberg, Mona Mari; Harandi, Ali M.; Thörn, Karolina; Grødeland, Gunnveig; Bogen, Bjarne & Brekke, Ole Henrik [Show all 7 contributors for this article] (2011). Vaccibodies as Proteins act as Effective Prophylactic Vaccines against Infectious Diseases. Scandinavian Journal of Immunology. ISSN 0300-9475. 73(4), p. 391–391.
  • Grødeland, Gunnveig; Fredriksen, Agnete; Mjaaland, Siri & Bogen, Bjarne (2011). Immunogenicity and Protective Efficacy of Targeted DNA Vaccine against Influenza. Scandinavian Journal of Immunology. ISSN 0300-9475. 73(4), p. 384–384.
  • Vorland, lars; Bovim, Gunnar; Gran, Jon Michael; Grødeland, Gunnveig; Hjort, Ingrid & Kristoffersen, Kathrine [Show all 11 contributors for this article] (2021). EKSPERTUTVALGET OM VIRUSVEKTORVAKSINER - Vurderinger av virusvektorvaksiner i og utenfor vaksinasjonsprogrammet. Regjeringen.no.

View all works in Cristin

Published Oct. 14, 2014 1:56 PM - Last modified Feb. 11, 2020 1:57 PM